Phase 4 Heart Disease Trial, Recruiting NCT06769256 Sponsor: Henan Institute of Cardiovascular Epidemiology Condition: Heart Disease
Back to Heart Disease

Phase 4 Heart Disease Trial, Recruiting

NCT06769256
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 75 years old
  • You are having a certain type of heart attack (called STEMI) and it started within the last 12 hours
  • During your heart procedure, blood flow in the blocked artery is still very limited or there is a large amount of clot present, even after initial attempts to clear it
  • Your procedure is being done through an artery in your wrist (radial access)

Who may not be able to join:

  • Your blocked heart artery is already receiving enough blood flow from other nearby blood vessels acting as a "backup supply"
  • You have had a previous heart attack in the same artery being treated
  • You are having this procedure as a last resort after other treatments (such as clot-busting drugs) have already been tried and failed
  • You are in severe heart failure causing dangerously low blood pressure (cardiogenic shock)
  • You have a known allergy or medical reason why you cannot take the study medications (Tirofiban or rhTNK-tPA)
  • You have serious liver or kidney problems, or are currently on dialysis
  • You needed more than 10 minutes of CPR (chest compressions/resuscitation) before the procedure
  • You have a serious physical complication from your heart attack, such as a hole in the heart wall or torn heart muscle
  • You have severe long-term lung disease or are in respiratory failure
  • You have a serious active infection
  • You have a neurological (brain or nerve) disorder (confirm with trial site)
  • You have cancer or another serious condition where life expectancy is less than one year
  • You are pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: +86 37158681037

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Henan Institute of Cardiovascular Epidemiology
Registry
ClinicalTrials.gov
Start date
1 January 2025
Est. completion
30 December 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Corrected TIMI frame count (CTFC)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov